Navigation Links
National Jewish, Brigham and Women's Awarded $37 Million to Identify Genes and Other Risk Factors that Influence the Development of COPD
Date:10/10/2007

DENVER, Oct. 10 /PRNewswire-USNewswire/ -- Researchers from National Jewish Medical and Research Center and Brigham and Women's Hospital have been awarded a $37 million grant from the National Heart Lung and Blood Institute (NHLBI) to lead the most comprehensive study of chronic obstructive pulmonary disease (COPD) ever undertaken. The multi-institutional study will seek to identify the genetic, epidemiological and radiological characteristics of COPD, with a long-term goal of better understanding the disease and finding more effective treatments.

"COPD is the fourth leading cause of death in the United States, and yet we know so little about the disease," said James Crapo, MD, professor of medicine at National Jewish and co-principal investigator of the study. "This study will help us determine which smokers are most at risk of developing the disease, who is most likely to have progressive disease, and how to more effectively treat it."

"Our goal with this massive project is to discover genes responsible for this chronic lung disease and to develop a comprehensive data sharing plan so that this study will become a national resource for the scientific community," said Edwin Silverman, MD, PhD, associate professor of medicine at BWH and co- principal investigator of the study.

The 16 clinical study centers involved will enroll a total of 10,500 participants, 3,500 of whom will be African American, a population whose COPD rates are rapidly growing and whose risk factors have not been adequately studied.

COPD is an umbrella term for a variety of progressive lung diseases, most commonly emphysema and chronic bronchitis, which damage lung tissue and make it difficult to breathe. Cigarette smoking causes the vast majority of COPD cases, but breathing in other kinds of lung irritants may also cause the disease. A mutation in the alpha-1 antitrypsin gene accounts for about one to

two percent of COPD cases, but researchers hypothesize oth
'/>"/>

SOURCE National Jewish Medical and Research Center
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
2. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
3. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
4. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
6. New Drugs in Multinational Study Show Promise in Fighting Drug-Resistant HIV
7. Suven Life Sciences Presenting Pre-clinical data of their NCE’s SUVN-502 and SUVN-507at International Brain Research Organization (IBRO) 2007 World Congress of Neuroscience
8. Nuvelo Announces Presentations on rNAPc2 and NU172 at the XXIst Congress of the International Society on Thrombosis and Haemostasis
9. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
10. Labopharm to Present Poster on Dose Titration of Once-daily Tramadol at 3rd International Forum on Pain Medicine
11. The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... NEW YORK , Nov. 26, 2014 /PRNewswire/ ... is growing at a rate of 4%, with ... according to Kalorama Information. MRI and other types ... the diagnosis and treatment of numerous medical conditions ... different technologies and techniques. Kalorama,s report, Medical ...
(Date:11/26/2014)... 25, 2014 According to ... Power Source (Electric, Battery, Pneumatic), by Product (Drill, ... Cart), by Application (Orthopedic, ENT, Oral, Thoracic, Neurology) ... global Powered Surgical Instruments Market is estimated to ... 2014 and is expected to grow at a ...
(Date:11/26/2014)... , Nov. 25, 2014  goBalto, Inc., the leading ... recognized as a winner of Red Herring,s Top ... Top 100 North America award in 2013, marking its ... landscape. Red Herring,s Top 100 Global list ... new companies and entrepreneurs. Red Herring editors were among ...
Breaking Medicine Technology:Kalorama: Steady Growth in the Medical MRI Market 2Kalorama: Steady Growth in the Medical MRI Market 3Powered Surgical Instruments Market Worth $2.1 Billion by 2019 2Powered Surgical Instruments Market Worth $2.1 Billion by 2019 3Powered Surgical Instruments Market Worth $2.1 Billion by 2019 4goBalto Selected as a 2014 Red Herring Top 100 Global Company 2goBalto Selected as a 2014 Red Herring Top 100 Global Company 3
... TransTech Medical Solutions is pleased to announce the expansion ... Center.  The new agreement increases the suite of services ... transcription and voice recognition editing services across a variety ... medical transcription and editing services provided by TransTech can ...
... 14, 2010 Samplify Systems, Inc., a leading ... ultrasound market, is pleased to announce that its ... won Electronic Design Magazine,s Best Electronic ...  Details of Samplify,s AutoFocus™ beamforming technology currently appear ...
Cached Medicine Technology:TransTech Medical Solutions Expands Offering to MD Anderson Cancer Center to Include Outsourced Medical Transcription and Editing Services 2Samplify's AutoFocus™ Beamforming Technology Awarded Electronic Design's 'Best of 2010' 2
(Date:11/28/2014)... (PRWEB) November 28, 2014 The ... healthy growth over the past five years. The ... acceptance of therapies that are either alternative to ... According to IBISWorld industry analyst David Whytcross, “industry ... population and growing private health insurance membership.” Meanwhile, ...
(Date:11/28/2014)... THURSDAY, Nov. 27, 2014 (HealthDay News) -- Planning on ... from chronic heartburn -- clinically known as gastroesophageal reflux disease ... Dr. Jordan Josephson, an ear, nose and throat specialist ... these tips to help manage GERD on Thanksgiving: ... have at least two small meals throughout the day. It,s ...
(Date:11/28/2014)... An inventor and dental assistant from Kent, Wash., was ... it was almost impossible to reach. "This gave me the ... The patent-pending Access Light allows for easier use of a ... mouth, as well as avoids harm to the lips, tongue ... and clean, it also helps prevent cross-contamination. , The original ...
(Date:11/28/2014)... A newly released article from Community Health ... virus that will soon be spreading across the United States ... with a brief explanation of what the influenza virus is ... children under the age of 5, adults over the age ... heart and lung diseases, asthma, or diabetes, are at higher ...
(Date:11/28/2014)... PA (PRWEB) November 28, 2014 "Most of ... forced me to use crutches," said an inventor from Findlay, ... more convenient way to support my foot, which inspired me ... Sling to offer a convenient way to support an injured ... get around. It eliminates the need for crutches. The design ...
Breaking Medicine News(10 mins):Health News:Alternative Health Therapies in Australia Industry Market Research Report Now Updated by IBISWorld 2Health News:Alternative Health Therapies in Australia Industry Market Research Report Now Updated by IBISWorld 3Health News:Alternative Health Therapies in Australia Industry Market Research Report Now Updated by IBISWorld 4Health News:Don't Let Chronic Heartburn Spoil Your Thanksgiving Feast 2Health News:How Flu Vaccines Can Impact Families Is Discussed in New Article from Community Health Center of Snohomish County 2
... Teens Face Greater Worries ... ... for a Drug-Free,America(R), in collaboration with MetLife Foundation, today announced the,results ... lives of their grandchildren. Released today, Grandparent,s Day, the,survey underscores the ...
... Sept. 8 At the National Press,Club,s 10th Annual ... National,Press Club at 14th & F in Washington, Weiner ... News, the news reporting and op-ed writing,division of Robert ... 60 op-eds in top 100 papers since Weiner left ...
... during delivery protect against potentially deadly infection , , FRIDAY, ... carries the bacterium Group B streptococcus, the most common ... don,t know it. , That same germ can wreak ... possibly leading to blindness, deafness, retardation, physical disability and, ...
... Better Ability to Improve Patient Care, LYNWOOD, ... Medical Center have reached a tentative agreement on ... will increase their ability to,advocate for improved patient ... a qualified and skilled staff. The agreement, ...
... Concentra Health Services, Inc.,("Concentra" or the "Company") recently ... LLC d/b/a WorkWise, consisting of two occupational,health centers ... will be consolidated into the existing Concentra Medical ... presence to two total,centers in the Birmingham market. ...
... higher material prices. ... the year., ST. LOUIS, Sept. 7 Allied Healthcare,Products, ... increased 38,percent to $869,000, or 11 cents per share, during ... cents per share, for the fourth,quarter last year. Despite ...
Cached Medicine News:Health News:Survey From The Partnership and MetLife Foundation Reveals Important Role Today's Grandparents Play in Teens' Lives 2Health News:Survey From The Partnership and MetLife Foundation Reveals Important Role Today's Grandparents Play in Teens' Lives 3Health News:Survey From The Partnership and MetLife Foundation Reveals Important Role Today's Grandparents Play in Teens' Lives 4Health News:Weiner Public News First Media Team at National Press Club 5K 2Health News:Group B Strep: A Threat to Newborns That Doesn't Have to Be 2Health News:Group B Strep: A Threat to Newborns That Doesn't Have to Be 3Health News:Group B Strep: A Threat to Newborns That Doesn't Have to Be 4Health News:Workers Win Contract at St. Francis Medical Center 2Health News:Concentra Acquires Assets of Renew Health & Wellness 2Health News:Allied Healthcare Reports Strong Fourth Quarter, Flat Net Income for Fiscal 2007 vs. 2006 2Health News:Allied Healthcare Reports Strong Fourth Quarter, Flat Net Income for Fiscal 2007 vs. 2006 3Health News:Allied Healthcare Reports Strong Fourth Quarter, Flat Net Income for Fiscal 2007 vs. 2006 4Health News:Allied Healthcare Reports Strong Fourth Quarter, Flat Net Income for Fiscal 2007 vs. 2006 5
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: